← SynDRA
ZSTK-474
SynDRA canonical compound SYN0019053 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
| Primary target(s) | PIK3CG |
| Mechanism of action | PI3K inhibitor |
All known targets
- PIK3CG
- PIK3CA
- PIK3CB
- PIK3CD
Mechanisms of action (all sources)
- PI3K inhibitor
- PIK3CA INHIBITOR
- PIK3CB INHIBITOR
- PIK3CD INHIBITOR
- PIK3CG INHIBITOR
- PIK3CG MODULATOR
Cross-references
Synonyms
- Zstk474
- TCMDC-137004
- ZSTK474
- ZSTK 474
- 4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine
- UNII-K0068GK39A
- CHEMBL586702
- CHEBI:90545
- K0068GK39A
- 2-(2-difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine
- 2-(2-Difluoromethylbenzimidazol-1-yl)-4,6-bis(morpholino)-1,3,5-triazine
- AK-40326
- 2-(Difluoromethyl)-1-(4,6-Dimorpholin-4-Yl-1,3,5-Triazin-2-Yl)-1h-Benzimidazole
- C19H21F2N7O2
- 2wxl
- PubChem22461
- SCHEMBL373282
- QCR-72
- GTPL7965
- CTK8B6247
- SYN1099
- RefChem:909420
- DTXCID90119670
- MFCD08705334
- orb1301016
- SCHEMBL29357859
- HGVNLRPZOWWDKD-UHFFFAOYSA-N
- HMS2043A02
- HMS3265I19
- HMS3265I20
- HMS3265J19
- HMS3265J20
- HMS3654I15
- EX-A2207
- BDBM50315213
- NSC764516
- NSC800993
- AKOS005145982
Look up ZSTK-474 in the interactive SynDRA portal →